GlaxoSmithKline on Monday said it was taking a stake in German vaccines maker CureVac, the latest move by a major drugmaker to boost capabilities to fight pandemics.

from MarketWatch.com - Top Stories https://ift.tt/2WDeLwW
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/2WDeLwW
via IFTTT
Kommentare
Kommentar veröffentlichen